Longitude (Cayman) Ltd. Amicus Therapeutics, Inc. Transaction History

Longitude (Cayman) Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$9.82 - $12.75 $245,500 - $318,750	25,000 New	25,000 $261,000
Q1 2022 May 12, 2022	SELL	$7.89 - $12.48 $1.29 Million - $2.03 Million	-163,000 Reduced 68.78%	74,000 $701,000
Q4 2021 Feb 03, 2022	SELL	$9.82 - $12.44 $471,360 - $597,120	-48,000 Reduced 16.84%	237,000 $2.74 Million
Q3 2021 Nov 08, 2021	BUY	$8.74 - $11.84 $253,460 - $343,360	29,000 Added 11.33%	285,000 $2.72 Million
Q2 2021 Aug 10, 2021	BUY	$8.71 - $10.72 $226,460 - $278,720	26,000 Added 11.3%	256,000 $2.47 Million
Q1 2021 May 11, 2021	BUY	$9.2 - $23.86 $1.33 Million - $3.46 Million	145,000 Added 170.59%	230,000 $2.27 Million
Q4 2020 Feb 11, 2021	BUY	$13.47 - $24.89 $1.14 Million - $2.12 Million	85,000 New	85,000 $1.96 Million

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Longitude (Cayman) Ltd., based on Form 13F filings with the SEC.

Stay updated on Longitude (Cayman) Ltd. with notifications on news.